Your browser doesn't support javascript.
loading
Dysregulation of Specialized Delay/Interference-Dependent Working Memory Following Loss of Dysbindin-1A in Schizophrenia-Related Phenotypes.
Petit, Emilie I; Michalak, Zuzanna; Cox, Rachel; O'Tuathaigh, Colm M P; Clarke, Niamh; Tighe, Orna; Talbot, Konrad; Blake, Derek; Joel, Josephine; Shaw, Alexander; Sheardown, Steven A; Morrison, Alastair D; Wilson, Stephen; Shapland, Ellen M; Henshall, David C; Kew, James N; Kirby, Brian P; Waddington, John L.
Afiliação
  • Petit EI; Molecular and Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin, Ireland.
  • Michalak Z; Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, NY, USA.
  • Cox R; Department of Physiology and Medical Physics, Royal College of Surgeons in Ireland, Dublin, Ireland.
  • O'Tuathaigh CM; Clinical and Experimental Epilepsy, University College London Institute of Neurology, London, UK.
  • Clarke N; Molecular and Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin, Ireland.
  • Tighe O; Molecular and Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin, Ireland.
  • Talbot K; School of Medicine, University College Cork, Cork, Ireland.
  • Blake D; Molecular and Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin, Ireland.
  • Joel J; Office of Research and Innovation, Royal College of Surgeons in Ireland, Dublin, Ireland.
  • Shaw A; Molecular and Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin, Ireland.
  • Sheardown SA; Department of Neurology, University of California at Los Angeles, Los Angeles, CA, USA.
  • Morrison AD; Institute of Psychological Medicine and Clinical Neurosciences, MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, Cardiff, UK.
  • Wilson S; Neurology Centre of Excellence for Drug Discovery, GlaxoSmithKline, Harlow, UK.
  • Shapland EM; Horizon Discovery, Cambridge, UK.
  • Henshall DC; Neurology Centre of Excellence for Drug Discovery, GlaxoSmithKline, Harlow, UK.
  • Kew JN; Neurology Centre of Excellence for Drug Discovery, GlaxoSmithKline, Harlow, UK.
  • Kirby BP; Takeda Cambridge, Cambridge, UK.
  • Waddington JL; Neurology Centre of Excellence for Drug Discovery, GlaxoSmithKline, Harlow, UK.
Neuropsychopharmacology ; 42(6): 1349-1360, 2017 May.
Article em En | MEDLINE | ID: mdl-27986973
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Atenção / Esquizofrenia / Comportamento Animal / Disbindina / Memória de Curto Prazo Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Atenção / Esquizofrenia / Comportamento Animal / Disbindina / Memória de Curto Prazo Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2017 Tipo de documento: Article